These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 22830633)

  • 21. Costs and cost-effectiveness of HIV community services: quantity and quality of studies published 1986-2011.
    Beck EJ; Fasawe O; Ongpin P; Ghys P; Avilla C; De Lay P
    Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):293-311. PubMed ID: 23763528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Costs of Delivering Integrated HIV and Sexual Reproductive Health Services in Limited Resource Settings.
    Obure CD; Sweeney S; Darsamo V; Michaels-Igbokwe C; Guinness L; Terris-Prestholt F; Muketo E; Nhlabatsi Z; ; Warren CE; Mayhew S; Watts C; Vassall A
    PLoS One; 2015; 10(5):e0124476. PubMed ID: 25933414
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Public and private donor financing for health in developing countries.
    Howard LM
    Infect Dis Clin North Am; 1991 Jun; 5(2):221-34. PubMed ID: 1869807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there scope for cost savings and efficiency gains in HIV services? A systematic review of the evidence from low- and middle-income countries.
    Siapka M; Remme M; Obure CD; Maier CB; Dehne KL; Vassall A
    Bull World Health Organ; 2014 Jul; 92(7):499-511AD. PubMed ID: 25110375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries.
    Marseille E; Dandona L; Marshall N; Gaist P; Bautista-Arredondo S; Rollins B; Bertozzi SM; Coovadia J; Saba J; Lioznov D; Du Plessis JA; Krupitsky E; Stanley N; Over M; Peryshkina A; Kumar SG; Muyingo S; Pitter C; Lundberg M; Kahn JG
    BMC Health Serv Res; 2007 Jul; 7():108. PubMed ID: 17626616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Scaling-up health information systems to improve HIV treatment: An assessment of initial patient monitoring systems in Mozambique.
    Hochgesang M; Zamudio-Haas S; Moran L; Nhampossa L; Packel L; Leslie H; Richards J; Shade SB
    Int J Med Inform; 2017 Jan; 97():322-330. PubMed ID: 27919390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia.
    Shiferaw F; Letebo M; Bane A
    BMC Public Health; 2016 Aug; 16(1):769. PubMed ID: 27514515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term financing needs for HIV control in sub-Saharan Africa in 2015-2050: a modelling study.
    Atun R; Chang AY; Ogbuoji O; Silva S; Resch S; Hontelez J; Bärnighausen T
    BMJ Open; 2016 Mar; 6(3):e009656. PubMed ID: 26948960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for economic evaluation alongside a multicentre trial in developing countries: a case study from the WHO Antenatal Care Randomised Controlled Trial.
    Mugford M; Hutton G; Fox-Rushby J
    Paediatr Perinat Epidemiol; 1998 Oct; 12 Suppl 2():75-97. PubMed ID: 9805724
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resource utilisation and cost of ambulatory HIV care in a regional HIV centre in Ireland: a micro-costing study.
    Brennan A; Jackson A; Horgan M; Bergin CJ; Browne JP
    BMC Health Serv Res; 2015 Apr; 15():139. PubMed ID: 25884351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
    Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
    Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessing the cost of providing a prevention of mother-to-child transmission of HIV/AIDS service in Ethiopia: urban-rural health facilities setting.
    Zegeye EA; Mbonigaba J; Kaye S; Johns B
    BMC Health Serv Res; 2019 Mar; 19(1):148. PubMed ID: 30841870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protecting the confidentiality and security of personal health information in low- and middle-income countries in the era of SDGs and Big Data.
    Beck EJ; Gill W; De Lay PR
    Glob Health Action; 2016; 9():32089. PubMed ID: 27885972
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Private companies: an opportunity for hepatitis B virus (HBV) prevention and care in Ivory Coast in the wake of HIV/AIDS?].
    Bekelynck A
    Bull Soc Pathol Exot; 2015 Feb; 108(1):57-62. PubMed ID: 25407333
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Unit cost repositories for health program planning and evaluation: a report on research in practice with lessons learned.
    Bollinger LA; Corlis J; Ombam R; Forsythe S; Resch SC
    BMC Public Health; 2023 Jun; 23(1):1055. PubMed ID: 37264335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The impact of disease stage on direct medical costs of HIV management: a review of the international literature.
    Levy A; Johnston K; Annemans L; Tramarin A; Montaner J
    Pharmacoeconomics; 2010; 28 Suppl 1():35-47. PubMed ID: 21182342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Setting health insurance remuneration rates of private providers in Kenya: the role of costing, challenges and implications.
    Mathauer I
    Int J Health Plann Manage; 2011; 26(1):e30-47. PubMed ID: 22392797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The private sector role in HIV/AIDS in the context of an expanded global response: expenditure trends in five sub-Saharan African countries.
    Sulzbach S; De S; Wang W
    Health Policy Plan; 2011 Jul; 26 Suppl 1():i72-84. PubMed ID: 21729920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Costs of providing HIV care and optimal allocation of HIV resources in Guyana.
    Suraratdecha C; Stuart RM; Edwards M; Moore R; Liu N; Wilson DP; Albalak R
    PLoS One; 2020; 15(10):e0238499. PubMed ID: 33119591
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.
    Olsson S; Pal SN; Stergachis A; Couper M
    Drug Saf; 2010 Aug; 33(8):689-703. PubMed ID: 20635827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.